Advertise on podcast: APOE4: Beat the Odds

Originally published on YouTube on 3 January 2026.Original video: https://www.youtube.com/watch?v=DDvQywa3ybU Free guide: The Doctor Conversation Kithttps://thephoenix.community/guides/doctor-conversation-kit If you have been told there is nothing you can do about APOE4, this episode is for you. I examine the gap between research and routine practice, the FINGER trial, blood pressure, diet, sleep and exercise, then walk through the actions discussed in this January 2026 recording. RESOURCESApply to join Phoenix: https://thephoenix.community/?utm_source=youtube&utm_medium=caption&utm_campaign=doctorwrongEssential APOE4 Guide: https://ebook.thephoenix.community/?utm_source=youtube&utm_medium=caption&utm_campaign=doctorwrongWeekly Newsletter: https://apoe4.co/?utm_source=youtube&utm_medium=caption&utm_campaign=doctorwrong CHAPTERS00:00 Intro01:13 Overview02:52 The knowledge gap05:43 APOE4 carriers benefit more09:06 The 85% solution - Blood pressure09:17 ApoE4 carriers compared to non-carriers with normal blood pressure11:28 Diet - The 35% advantage13:17 The core Mediterranean diet principles14:30 Sleep, exercise and the emerging future16:51 Your action plan for this week

Originally published on YouTube on 19 January 2026.Original video: https://www.youtube.com/watch?v=PCVvtsuCA7M Free guide: The APOE4 Optimizer's Stackhttps://thephoenix.community/guides/optimizer-stack As an APOE4/4 carrier who travels frequently, I have developed a system for keeping my routine on the road. I cover portable supplements, hotel workouts, sleep away from home and restaurant choices, plus the practical compromises I make while traveling. RESOURCESApply to join Phoenix: https://apoe4.link/YTtravelEssential APOE4 Guide: https://apoe4.link/YTtravelguideWeekly Newsletter: https://apoe4.link/YTtravelN CHAPTERS00:00 Introduction01:43 Portable Supplements09:42 Hotel Workouts13:25 Sleep Optimisation17:00 Restaurant Strategies20:31 Key Takeaways and Closing ORIGINAL LINKS AND REFERENCESAPOE4 Carriers: How to Clean Amyloid from Your Brain While You Sleep (Science Deep Dive) https://youtu.be/SsSBwVtaCBI

Originally published on YouTube on 28 January 2026.Original video: https://www.youtube.com/watch?v=mQMjG1HJ-yo Free guide: The APOE4 Blood Work Blueprinthttps://apoe4.link/Bloodguide What blood work do I run as an APOE4/4 carrier? I walk through my panel, how I interpret the results, the tests I repeat and the markers discussed in the episode. The original research references and Blood Work Blueprint are included below. RESOURCESApply to join Phoenix: https://apoe4.link/LbloodpanelEssential APOE4 Guide: https://apoe4.link/YTbloodpanelWeekly Newsletter: https://apoe4.link/YTBloodwork CHAPTERS00:00 Intro02:26 Why standard ranges don't apply to ApoE403:57 The Inflammation Panel07:21 The Lipid Panel Upgrade10:34 Metabolic Health Markers14:09 Nutrient Status17:40 Hormone Panel19:33 Testing Frequency By Age21:10 The Phoenix Community ORIGINAL LINKS AND REFERENCESTao Q, et al. Association of Chronic Low-grade Inflammation With Risk of Alzheimer Disease in ApoE4 Carriers. JAMA Network Open. 2018. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2707427Smith AD, et al. Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy. PLoS One. 2010. https://pmc.ncbi.nlm.nih.gov/articles/PMC2935890/Seshadri S, et al. Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease. NEJM. 2002. https://www.nejm.org/doi/full/10.1056/NEJMoa011613Jerneren F, et al. Brain atrophy in cognitively impaired elderly: the importance of omega-3 fatty acids and B vitamin status. Am J Clin Nutr. 2015. https://pubmed.ncbi.nlm.nih.gov/25877495/Zhao N, et al. Apolipoprotein E4 impairs neuronal insulin signaling. Neuron. 2017. https://pmc.ncbi.nlm.nih.gov/articles/PMC5621659/Sniderman AD, et al. Apolipoprotein B Particles and Cardiovascular Disease. JAMA Cardiol. 2019. https://pmc.ncbi.nlm.nih.gov/articles/PMC7369156/Ebright B, et al. Effects of APOE4 on omega-3 brain metabolism across the lifespan. Trends Endocrinol Metab. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11321946/Chen HY, et al. Ageing related thyroid deficiency increases brain-targeted transport of liver-derived ApoE4-laden exosomes. Cell Death Dis. 2022. https://www.nature.com/articles/s41419-022-04858-xSaleh RNM, et al. Hormone replacement therapy is associated with improved cognition in at-risk APOE4 women. Alzheimers Res Ther. 2023. https://alzres.biomedcentral.com/articles/10.1186/s13195-022-01121-5

Originally published on YouTube on 3 February 2026.Original video: https://www.youtube.com/watch?v=ZiDlorwfCAA Free guide: The APOE4 Brain Biomarker Guidehttps://thephoenix.community/guides/brain-biomarkers I sit down with Julia from Premaz to discuss visual-spatial cognitive testing, tracking changes over time, the effects of other factors on a test result, and how cognitive testing fits alongside blood tests and scans. The conversation includes Premaz and its Phoenix integration at the time of recording. RESOURCESAPOE4 Blood Work Blueprint: https://apoe4.link/BloodguideApply to join Phoenix: https://apoe4.link/YTPremazEssential APOE4 Guide: https://apoe4.link/PremazWeekly Newsletter: https://apoe4.link/premazN CHAPTERS00:00 Intro02:04 A Test That Can Measure Cognition - Premaz Explained11:03 How Often Should People Test?12:12 Impact of other factors on the test14:00 Best Age Frame to Test16:25 How does Premaz fit with blood tests and other scans?18:45 Members Questions21:11 Testing in Older Adults22:27 Positives and Negatives of Visual Testing24:01 Conclusion

Thinking about joining an Alzheimer's prevention trial as a healthy APOE4 carrier? Here's what it asks of you, and what to ask back. Jessica Langbaum, PhD, of Banner Alzheimer's Institute has spent her career recruiting people into Alzheimer's prevention studies. Our members asked the questions: would I have to stop my supplements, is placebo fair, what about ARIA with two copies? Watch the video on YouTube: https://youtu.be/I5iYOTNucDw WHAT WE COVER• The three things to weigh before you say yes: time, the results you'll learn, the risk• How to find a trial, and how long it takes to get in• What trials usually cover: travel, parking, hotels• Why a prevention trial can ask you to stop supplements• What you still get on placebo, and why placebo exists• ARIA with two copies of APOE4: what she'd check first• Blood tests like p-tau217, and joining from far away• Which prevention trials are coming next• Why two copies is a risk, not a sentence WANT YOUR QUESTION IN THE NEXT INTERVIEW?Members can submit questions before future interviews. Not every question fits. Phoenix also helps you build your personal protocol, review your own blood tests and find support from other carriers.Apply to join Phoenix: https://apoe4.link/JessicaQnA LINKS• Alzheimer's Prevention Registry (open to anyone 18+, anywhere): https://www.endalznow.org/s/?utm_campaign=%20the-phoenix-%20apoe4&utm_medium=podcastl&utm_source=%20the-phoenix• Free APOE4 clinical trial finder: https://apoe4.link/JessicaQnAT RESOURCES• Guide: https://apoe4.link/JessicaQnAG• Free newsletter: https://apoe4.link/JessicaQnAN TRIALS MENTIONED• PrevenTRON (Roche, trontinemab), announced at AAIC 2026: https://www.biospace.com/press-releases/roche-presents-new-data-in-alzheimers-disease-from-across-its-integrated-pharmaceutical-and-diagnostics-portfolio-at-aaic• SPINOZA (NewAmsterdam, obicetrapib): https://clinicaltrials.gov/study/NCT07794670 A NOTE ON WHAT THIS ISI'm Dr. Kevin Tran, a Doctor of Pharmacy. I carry two copies of APOE4.Education, not medical advice. Every trial is different: the study team and the informed consent are your source for a specific study. APOE4 is a risk factor, not a diagnosis. CHAPTERS00:00 Should you join an Alzheimer's prevention trial?02:04 What should a carrier weigh before saying yes?05:18 How do you find a prevention trial?08:35 How long does it take to get in?09:33 Do you need a study partner?10:07 Who pays for travel and hotels?11:17 What else should you ask the study team?12:21 What is GeneMatch, and can you still join?16:06 Will a trial make you stop your supplements?18:12 Is it ethical to come off for a placebo?19:42 Is the placebo arm wasted time?22:19 Two copies and ARIA: what to check first24:08 Can you join if you live far from a site?26:52 Which prevention trials are coming next?30:39 Do trial sites redo your tests?31:44 Does two copies mean you'll get Alzheimer's?33:38 How can carriers help research?36:19 Kevin's close

Originally published on YouTube on 21 February 2026.Original video: https://www.youtube.com/watch?v=z7rxmVLAMT0 Free guide: The APOE4 Emerging Therapies Watchlisthttps://thephoenix.community/guides/emerging-therapies In this expert Q&A, Dr. Grant Fraser shares his clinical experience with rapamycin and discusses Dr. Alan Green's APOE4 patient observations. We cover mTOR, dosing and monitoring, cycling, side effects, sleep medications and timing around exercise. This is the February 2026 conversation. RESOURCESApply to join Phoenix: https://apoe4.link/RapamycinEssential APOE4 Guide: https://apoe4.link/RapamycinGWeekly Newsletter: https://apoe4.link/RapamycinN CHAPTERS00:00 Introduction05:03 Understanding Rapamycin: Mechanism and Benefits10:13 Clinical Experience With APOE4 Carriers16:13 Monitoring and Adjusting the Dosage27:59 Addressing Concerns in the Longevity Community30:30 Right Age To Start31:54 Dr. Green's Legacy34:45 Q&A and Conclusion

Originally published on YouTube on 1 March 2026.Original video: https://www.youtube.com/watch?v=-uu0L2Y-PlI Free guide: The APOE4 Supplement Guidehttps://thephoenix.community/guides/supplement-guide A December 2025 Cell Reports Medicine study reported cognitive recovery in mouse models of advanced Alzheimer's after restoring NAD+ homeostasis. I explain the study, the researchers' warning about over-the-counter NAD+ precursors, and the exercise, diet and inflammation strategies discussed in the episode. RESOURCESApply to join Phoenix: https://apoe4.link/NADEssential APOE4 Guide: https://apoe4.link/NADGWeekly Newsletter: https://apoe4.link/NADN CHAPTERS00:00 Introduction01:45 What is NAD+ and why it matters02:40 The Alzheimer's Paradox: NDAN Individuals03:43 The breakthrough study explained04:47 Safety warning about supplements07:13 Natural ways to support NAD+09:46 Reducing NAD+ consumption10:50 Key takeaways14:42 Conclusion ORIGINAL LINKS AND REFERENCESKetosis and APOE4: Why Generic Keto Fails (And What Actually Works) https://youtu.be/ayi3qDYeYvoZone 2 Training for APOE4: Your Exact Heart Rate Targets For Maximum Brain Health - https://youtu.be/XnRBrxA0Z_Uhttps://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(25)00608-1Harrington Discovery Institute / Case Western Reserve University Press Release: https://www.harringtondiscovery.org/news-media/2025/12/22/new-study-shows-alzheimers-disease-can-be-reversed-in-animal-models-to-achieve-full-neurological-recWu et al. (2025). NR supplementation clinical trial: https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/trc2.70023Nick Norwitz NAD+ analysis: https://staycuriousmetabolism.substack.com/p/never-get-alzheimers-disease-theNorwitz NG, et al. (2021). Precision Nutrition for Alzheimer's Prevention in ApoE4 Carriers: https://www.mdpi.com/2072-6643/13/4/1362

Originally published on YouTube on 17 February 2026.Original video: https://www.youtube.com/watch?v=ayi3qDYeYvo Free guide: The APOE4 Metabolic Guidehttps://thephoenix.community/guides/metabolic-guide As an APOE4/4 carrier, I have spent years researching and experimenting with ketogenic approaches. I compare the clinical trials, explain the differences between MCTs, and walk through my cycling approach and a framework for adapting ketosis to APOE4. RESOURCESApply to join Phoenix: https://apoe4.link/KetoEssential APOE4 Guide: https://apoe4.link/KetoGWeekly Newsletter: https://apoe4.link/KetoN CHAPTERS00:00 Introduction00:39 The Brain Energy Crisis02:20 Why Generic Keto Fails APOE4 Carriers05:57 APOE4-Specific Modifications07:52 The Cycling Approach - When to Use Ketosis11:34 Practical Application13:53 Key Takeaways15:44 Conclusion ORIGINAL LINKS AND REFERENCESAC-1202 Trial (Henderson et al., 2009): https://pmc.ncbi.nlm.nih.gov/articles/PMC2731764/BENEFIC Trial (Fortier et al., 2021): https://pmc.ncbi.nlm.nih.gov/articles/PMC8048678/MCT Ketogenic Effects (Lin et al., 2021): https://pmc.ncbi.nlm.nih.gov/articles/PMC8650700/Brain Ketone Review (Cunnane et al., 2016): https://pmc.ncbi.nlm.nih.gov/articles/PMC4937039/APOE4 Neuroimaging (Brandon et al., 2018): https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2018.00180/fullAPOE4+ Case Study (Morrill & Gibas, 2019): https://pubmed.ncbi.nlm.nih.gov/31336463/Ketones & Neurodegeneration (Jensen et al., 2020): https://pmc.ncbi.nlm.nih.gov/articles/PMC7699472/Exogenous Ketones (Stubbs et al., 2017): https://pmc.ncbi.nlm.nih.gov/articles/PMC5670148/Keto & Athletes (McSwiney et al., 2019): https://pmc.ncbi.nlm.nih.gov/articles/PMC6863116/Keto & Performance 2023 (Borszcz et al., 2023): https://pubmed.ncbi.nlm.nih.gov/37144460/APOE4 & Saturated Fat (Griffin et al., 2018): https://pmc.ncbi.nlm.nih.gov/articles/PMC6213759/Ketosis & Cognition Review (Altayyar et al., 2022): https://pmc.ncbi.nlm.nih.gov/articles/PMC8840718/

Two copies of APOE4. Does every memory lapse mean something, and would more testing help?Dr. Gayatri Devi explains why she starts with a cognitive baseline, not constant self-checking. Dr. Devi directs Park Avenue Neurology in New York and is Clinical Professor of Neurology and Psychiatry at the Zucker School of Medicine at Hofstra/Northwell. I went in with concerns Phoenix members had raised about memory lapses and testing before symptoms. I did not ask the submitted questions on camera. Several of those concerns still came up. WANT YOUR QUESTION IN THE NEXT INTERVIEW? Members can submit questions before future interviews. Not every question fits. Phoenix also helps you build your personal protocol, review your own blood tests and find support from other carriers.Apply to join Phoenix: https://apoe4.link/GayatriQnA1 RESOURCES→ Brain Biomarker Guide: https://apoe4.link/GayatriQnA1G→ Free newsletter: https://apoe4.link/GayatriQnA1N→ Free Clinical Trial Engine: https://apoe4.link/GayatriQnA1C A NOTE ON WHAT THIS IS Educational, not medical advice or a product endorsement. Take this to your own clinician. APOE4 is a risk factor, not a diagnosis. KEY TAKEAWAYS1. A useful baseline measures more than memory. Language, visual-spatial skills and switching tasks also matter. An age-average score may not reflect your own earlier ability.2. Repeating tests can improve test familiarity. Dr. Devi tells her patients to leave at least a year between routine assessments. This is not a rule to delay care for new symptoms.3. A positive p-tau217 result needs context. She discusses whether amyloid is present, not a person's odds of developing dementia.4. She notes that most people in their 80s with amyloid are cognitively intact. That does not mean someone will never develop symptoms. Her amyloid case series is unpublished.5. Her priorities include aerobic exercise, blood vessel health, sleep and stress. Her more proactive views on scans and treatment before symptoms go beyond the guidance and trial evidence she describes. QUESTIONS FOR YOUR CLINICIANWhat would this test measure? How would you interpret it for someone like me? What would change after a positive, negative or unclear result?These are discussion prompts, not a testing or treatment protocol. Full sources and limits are in the original YouTube description. WHAT WE COVER 00:00 Teaser01:10 Why a second APOE4 copy matters02:34 What two copies of APOE4 means, and why age at discovery matters05:22 What a proper baseline test includes07:42 Practice effect: how often to retest08:54 Biomarkers vs. real risk: why plaques don't always mean dementia14:41 How reliable is the P-tau217 blood test?16:01 Handling the anxiety: sleep and other no-brainer interventions17:58 Amyloid scans for people without symptoms20:08 The amyloid hypothesis and anti-amyloid drugs24:17 ARIA brain bleed risk and slow dosing26:48 Final advice from Dr. Devi28:30 Outro: Kevin's three takeaways

Originally published on YouTube on 25 February 2026.Original video: https://www.youtube.com/watch?v=XnRBrxA0Z_U Free guide: The APOE4 Exercise Protocolhttps://thephoenix.community/guides/exercise-protocol I explain Zone 2 training for APOE4 carriers: how the MAF formula estimates a heart-rate range, how to use the talk test, what to track and how to combine aerobic training with higher-intensity exercise. The episode includes a sample training week and the research behind the approach. RESOURCESApply to join Phoenix: https://apoe4.link/Zone2Essential APOE4 Guide: https://apoe4.link/Zone2GWeekly Newsletter: https://apoe4.link/Zone2N CHAPTERS00:00 Introduction02:06 Why Zone 2 Matters for APOE4 Brains05:07 Calculating Your Zone 2 Heart Rate05:40 MAF Formula Calculation10:04 Tracking Methods and Weekly Protocol11:56 Why You Need HIIT Too13:47 Key Takeaways15:22 Conclusion ORIGINAL LINKS AND REFERENCES- Erickson et al. 2011 - Aerobic exercise increases hippocampal volume by 2% https://pubmed.ncbi.nlm.nih.gov/21282661/- Kaufman et al. 2021 - APOE4 carriers show greater blood flow improvement from exercise https://pmc.ncbi.nlm.nih.gov/articles/PMC8327103/- De la Rosa et al. 2020 - Meta-analysis: 45% AD risk reduction from regular exercise https://pmc.ncbi.nlm.nih.gov/articles/PMC7498620/- Tokgoz & Claassen 2021 - Exercise as treatment for APOE4 carriers (systematic review) https://pmc.ncbi.nlm.nih.gov/articles/PMC8126521/- FINGER Trial - Lifestyle interventions benefit APOE4 carriers MORE https://www.alzdiscovery.org/cognitive-vitality/blog/healthy-lifestyle-changes-may-benefit-cognition-in-older-people-with-apoe4- Hu et al. 2021 - HIIT stimulates BDNF expression in hippocampus https://pmc.ncbi.nlm.nih.gov/articles/PMC7946986/- Park et al. 2021 - High-intensity exercise and hippocampal mitochondrial biogenesis https://pmc.ncbi.nlm.nih.gov/articles/PMC8481603/

Originally published on YouTube on 15 April 2026.Original video: https://www.youtube.com/watch?v=Xoq4DTX_YtM Free guide: The APOE4 Diet Playbookhttps://thephoenix.community/guides/diet-playbook What did the 2026 JAMA Network Open study actually find about meat and APOE4? I walk through the study, processed versus unprocessed meat, its limitations and what I am doing with the findings, alongside the broader research on lifestyle and cognition. RESOURCESApply to join Phoenix: https://apoe4.link/MeatEssential APOE4 Guide: https://apoe4.link/MeatGWeekly Newsletter: https://apoe4.link/MeatN CHAPTERS00:00 Introduction01:16 What the Study Found03:16 Processed vs Unprocessed Meat04:55 Why This Doesn’t Prove Cause05:20 Limits of this study07:42 What Should APOE4 Carriers Eat?11:06 Lifestyle Matters More13:49 Conclusion ORIGINAL LINKS AND REFERENCES1. Norgren J et al. "Meat Consumption and Cognitive Health by APOE Genotype." JAMA Network Open. 2026 https://doi.org/10.1001/jamanetworkopen.2026.64892. Jin X et al. "APOE e4 genotype and lifestyle with cognitive function." PLoS Med. 2021 https://doi.org/10.1371/journal.pmed.10035973. Zhong WF et al. "Combined effects on cognitive impairment with APOE consideration." Alzheimers Res Ther. 2025 https://doi.org/10.1186/s13195-025-01806-74. Moon SY et al. "SUPERBRAIN-MEET RCT." Alzheimers Dement. 2025 https://doi.org/10.1002/alz.145175. Sun Y et al. "Cognitive Activities, Lifestyle, and APOE4." Gerontology. 2023 https://doi.org/10.1159/0005311096. Clinical Trial: ALA Nutrition for APOE4 MCI (NCT07392723) https://clinicaltrials.gov/study/NCT07392723

Originally published on YouTube on 27 April 2026.Original video: https://www.youtube.com/watch?v=oY_R_VOiwys Free guide: The APOE4 Woman's Guidehttps://thephoenix.community/guides/womens-guide Should APOE4 carriers consider hormone replacement therapy? I review research on HRT, menopause, testosterone and Alzheimer's risk, including the Women's Health Initiative, timing, formulation, APOE4-specific findings and the clinical trials discussed in this April 2026 recording. RESOURCESApply to join Phoenix: https://apoe4.link/HRTEssential APOE4 Guide: https://apoe4.link/HRT-GWeekly Newsletter: https://apoe4.link/HRT-N CHAPTERS00:00 Introduction02:23 WHI Study What Was Studied vs What Wasn't06:31 The Critical Window : Timing Is Everything09:38 Why ApoE4 Changes Everything14:19 Formulation Matters: Patches, Pills & Progesterone19:09 Men, APOE4 & Testosterone22:44 Clinical Trials Being Studied Right Now23:10 Active Clinical Trials26:19 5 Steps To Take This Week ORIGINAL LINKS AND REFERENCESSaleh et al. 2023 (EPAD): https://doi.org/10.1186/s13195-022-01121-5Melville et al. 2025 (Lancet): https://doi.org/10.1016/j.lanhl.2025.100803Nerattini et al. 2023: https://doi.org/10.3389/fnagi.2023.1260427Whitmer et al. 2011: https://doi.org/10.1002/ana.22239Kantarci et al. 2016 (KEEPS): https://doi.org/10.3233/JAD-160258Wang/Brinton 2025: https://doi.org/10.3389/fnagi.2025.1632877Blanchard et al. 2022 (Nature): https://doi.org/10.1038/s41586-022-05439-wYeap & Flicker 2022: https://doi.org/10.1007/s11154-022-09728-7Burkhardt et al. 2006: https://doi.org/10.1210/jc.2005-1072

Originally published on YouTube on 9 June 2026.Original video: https://www.youtube.com/watch?v=wbDdVGjvdFc Using diet, psyllium husk and ezetimibe, I lowered my ApoB nearly 40%, from 115 to about 70, without a statin. I walk through my lab panels, the changes I made and the evidence available at the time of this June 2026 recording, including what I was still watching next. RESOURCESApply to join Phoenix: https://apoe4.link/EzetimibeAPOE4 Lipid Playbook: https://apoe4.link/EzetimibeGWeekly Newsletter: https://apoe4.link/EzetimibeNAPOE4 Blood Work Blueprint: https://apoe4.link/EzetimibeB CHAPTERS00:00 Introduction03:18 Why APOE4 cholesterol is a different disease07:29 My actual baseline09:59 Lever 1: Diet (what I actually eat)10:50 The Mediterranean pattern11:35 The 4 moves I made14:53 Lever 2: Psyllium husk (the underestimated one)19:41 Lever 3: Ezetimibe (the standout lever, and why I skipped the statin)28:25 2026 ACC/AHA guideline29:35 The EZ-PAVE trial31:05 SWEDEHEART registry results32:37 The results35:57 Honest caveats + what I'm watching next38:58 My lipid blueprint for APOE4 carriers REFERENCESFiber: Jovanovski 2018 PMID30239559; Gibb 2015 PMID26561625; Zhu 2024 PMID38688104; Ghavami 2023 PMID36796439; McRorie 2017 PMID27863994; Schoeneck 2021 PMID33762150; Brum 2018 PMID30078477; Juhász 2023 PMID36811560. APOE4: Liu 2025 PMID40855194; Husain 2021 PMC7925634; Mahley 2016 PMC4942259; Dunk 2022 PMID34958023; Sniderman 2019 PMC7369156. Ezetimibe: Nordestgaard 2025 PMID41059729 DOI10.1002/alz.70638; Ganne 2024 PMID39263528; Gorbunova 2024 PMC11927789; Rossi 2025 PMID41400788; Mark 2007 PMID17559752; Pandor 2009 PMID19141093; Ouchi 2019 PMID31434507; Garcia-Calvo 2005 PMID15928087; Cannon 2015 IMPROVE-IT; Awad 2018 PMID29396832; Lee 2021 PMC7935639. Statins: Rajan 2024 PMID38447103; Westphal Filho 2025 PMC11736423; Banach 2025 PMID40126455. 2026: ACC/AHA Guideline; Ez-PAVE NCT04626973; Leosdottir 2025 PMID40240093.

Originally published on YouTube on 6 June 2026.Original video: https://www.youtube.com/watch?v=V72QViR99hk Why does sleep matter so much for APOE4 carriers? I explain the research, how to distinguish physical sleep problems from stress, what to track, and the tools, supplements and devices discussed in the episode. The episode includes device recommendations and PHOENIX discount codes. The original device links are preserved below. RESOURCESApply to join Phoenix: https://apoe4.link/SleepAPOE4 Sleep & Glymphatic Protocol: https://apoe4.link/SleepGWeekly Newsletter: https://apoe4.link/SleepN CHAPTERS00:00 Introduction01:43 WHY SLEEP MATTERS MORE FOR APOE4 CARRIERS04:19 YOUR TARGET METRICS06:29 DIAGNOSE FIRST - PHYSICAL ISSUES08:34 Rule this out09:43 DIAGNOSE - MENTAL AND STRESS ISSUES11:11 Here's how to identify if stress is your issue12:55 TOOLS AND DEVICES16:45 OPTIMIZATIONS18:19 Supplements That Have Evidence20:25 TRACKING AND THE PHOENIX APP22:05 Key Takeaways ORIGINAL LINKS AND REFERENCESZenowell (vagus nerve stimulation): https://zenowell.comNeuronic (photobiomodulation): https://neuronic.comAndre C et al. (2024). "Reduced rapid eye movement sleep in late middle-aged and older apolipoprotein E e4 allele carriers." Sleep. https://pmc.ncbi.nlm.nih.gov/articles/PMC11236949/Yu X et al. (2024). "Sleep and APOE-e4 have a synergistic effect on plasma biomarkers and longitudinal cognitive decline." CNS Neuroscience & Therapeutics. https://pmc.ncbi.nlm.nih.gov/articles/PMC10850800/Lee H et al. (2015). "The Effect of Body Posture on Brain Glymphatic Transport." J Neuroscience. https://pmc.ncbi.nlm.nih.gov/articles/PMC4524974/Hausenblas HA et al. (2024). "Magnesium-L-threonate improves sleep quality." Sleep Medicine X. https://pmc.ncbi.nlm.nih.gov/articles/PMC11381753/Robbins R et al. (2024). "Accuracy of Three Commercial Wearable Devices for Sleep Tracking." Sensors. https://pmc.ncbi.nlm.nih.gov/articles/PMC11511193/

Originally published on YouTube on 1 July 2026.Original video: https://www.youtube.com/watch?v=oYAvOrTa1MQ What's the best omega-3 for the APOE4 brain, and what dose? I compare the studies behind conflicting headlines, explain the difference between heart and brain goals, and explore fish oil, krill and LPC-DHA. I also cover the Omega-3 Index, supplement safety and what I take myself. The episode includes a product recommendation and a PHOENIX discount code. The original product link is preserved below. RESOURCESApply to join Phoenix: https://apoe4.link/LPCAPOE4 Supplement Guide: https://apoe4.link/LPCGWeekly Newsletter: https://apoe4.link/LPCN CHAPTERS00:00 Introduction01:36 Chapter 1 - Why Both Headlines Are True03:40 Chapter 2 - The Part Nobody Talks About08:04 Chapter 3 - What to Actually Buy11:24 Chapter 4 - How to Know It’s Working (+ Safety)14:41 Three Omega-3 Risks to Know15:59 Conclusion16:34 The Three Takeaways ORIGINAL LINKS AND REFERENCESProduct link (PHOENIX discount code mentioned in the July 2026 recording): https://www.fenixhealthscience.com/products/accentrate-omega-max?sca_ref=10391057.2Xbj1rXVxYX8I7&sca_source=phoenix1. Liao et al. 2026, J Prev Alzheimer's Dis: https://www.sciencedirect.com/science/article/pii/S22745807260009322. Wei et al. 2023, AJCN: https://pmc.ncbi.nlm.nih.gov/articles/PMC10447496/3. Sugasini et al. 2017, Scientific Reports: https://pmc.ncbi.nlm.nih.gov/articles/PMC5596017/4. Patrick 2019, FASEB Journal: https://pmc.ncbi.nlm.nih.gov/articles/PMC6338661/5. Nguyen et al. 2014, Nature: https://pubmed.ncbi.nlm.nih.gov/24828044/6. Harris & von Schacky 2004, Preventive Medicine: https://pubmed.ncbi.nlm.nih.gov/15208005/